Indira IVF has partnered with Creation Science IVF, the operator of Srishti Hospital in Puducherry, marking its official entry into the region’s fertility care market. This strategic stake acquisition will enhance access to advanced assisted reproductive technology (ART) services in Puducherry.

Srishti Hospital is a well-established fertility center equipped with modern infrastructure and a skilled clinical team offering ART solutions for both men and women. The hospital will continue to be led by Dr. Soumyaroop Dash and his team, ensuring uninterrupted and high-quality care in IVF and fertility treatments.

India is witnessing a rising demand for fertility treatments, influenced by changing lifestyles, heightened awareness, and an increase in chronic health conditions. Puducherry, with a Total Fertility Rate of 1.5 according to the NFHS-5, below the population replacement rate, reflects a growing need for accessible and effective fertility care.

By bringing Srishti Hospital into its nationwide network, Indira IVF plans to introduce standardized treatment protocols, digital healthcare support systems, and streamlined processes. This collaboration is aimed at improving care quality, enhancing patient experience, and offering more consistent, evidence-based fertility solutions in the region.

With this move, Indira IVF continues to expand its footprint across India, reaffirming its commitment to addressing fertility challenges with innovative and patient-centric solutions.